Isolyser (OREX)- Any comments Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Isolyser (OREX)- Any comments

OREX 0.223

-34.4%

Apr 3 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: van wang who wrote (469)	7/2/1997 11:38:00 AM
From: RGM	of 617

I believe that some comments that you made on your note were too subjective. Since you do not own any OREX, this reply is intended for present OREX shareholders. I reside in the same county as OREX. They have been a customer of mine for telecommunication services for the last four years. I own shares in OREX as a long-term investment. The question in my mind is how long do I need to hold onto OREX to reach my $5 1/8 breakeven. Spoke with Rick Copland yesterday at the EPA at (919) 541-5265. I wanted to get an update on the status of the EPA's issuance of their "Air Regulations for Medical Waste Incinerators" regulations which has been updated as of June, 1996. Rick told me that these regulations are going to be issued sometime this month for an probably effective date of January, 1998. During the next several years, these regulations will give OREX's products a proprietary niche in the hospital supply marketplace. It will be more cost effective for hospitals to use OREX products than to spend the capital dollars to upgrade their incinerators. OREX's problem during the last few years has been with the large buying groups for hospitals. The issuance of this EPA regulation is the government backing that OREX needs to break the hospital buying group's resistance. With the current price around $3 a share and a book value in the $4.50 per share range, OREX may be a cheap acquisition target for another healthcare company to acquire OREX's current products and its patents. It may be in OREX's best interest to be acquired so that they may obtain the funding to expand their product line and for quick entry into the hospital buying groups.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next